An interventional study of Rhythmic walking in Renal Function, sponsored by Burapha University. Completed at 1 site in Thailand. Open to participants aged 18 Years to 59 Years. Per ClinicalTrials.gov, last updated 2025-07-11.
Sponsored by Burapha University · Not applicable, Interventional, and Treatment
This study designed a over-knee automatic step counter device. Then, we evaluated its efficacy on renal function and oxidative stress in patients with chronic kidney disease.
This study is a randomized controlled trial. Patients who consent to participate and pass the screening process will be randomly assigned to groups based on the order of their participation (random by sequence). Patients who join in odd-numbered order, such as 1st, 3rd, 5th, etc., will receive standard care as provided by the hospital (control group). Patients who join in even-numbered order, such as 2nd, 4th, 6th, etc., will receive a walking program. This involves continuous walking exercise for 30 minutes, once a day, three days a week, over a period of three months. During the walking sessions, patients will walk at a pace of 60 steps per minute, or one step per second.
Burapha University is the lead sponsor of 12 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients who join in odd-numbered order, such as 1st, 3rd, 5th, etc., will receive standard care as provided by the hospital (control group).
Patients who join in even-numbered order, such as 2nd, 4th, 6th, etc., will receive a walking program. This involves continuous walking exercise for 30 minutes, once a day, three days a week, over a period of three months. During the walking sessions, patients will walk at a pace of 60 steps per minute, or one step per second.
Other: Rhythmic walking
Patients who consent to participate and pass the screening process were randomly assigned to groups based on the order of their participation (random by sequence): control group or rhythmic walking group.
Creatinine level
Blood creatinine level was measured in mg/dL unit
Time frame: Day 0 and day 91
Malondialdehyde level
Blood malondialdehyde level was measured in micromolar unit
Time frame: Day 0 and day 91
Superoxide dismutase activity level
Blood superoxide dismutase activity level was measured in percent unit
Time frame: Day 0 and day 91
Estimated glomerular filtration rate level
Estimated glomerular filtration rate level was measured in ml/min/1.73 m2 unit
Time frame: Day 0 and day 91
Estimated creatinine clearance level
Estimated creatinine clearance level was measured in ml/min unit
Time frame: Day 0 and day 91
Plan to share: No — There is no plan to make individual participant data (IPD) available to other researchers.
No publications or documents are linked to this record.
This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Burapha University